American Century Companies’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$787K Buy
78,949
+4,417
+6% +$44K ﹤0.01% 2373
2025
Q1
$445K Buy
74,532
+6,595
+10% +$39.4K ﹤0.01% 2554
2024
Q4
$522K Buy
67,937
+4,727
+7% +$36.3K ﹤0.01% 2492
2024
Q3
$645K Buy
63,210
+16,888
+36% +$172K ﹤0.01% 2387
2024
Q2
$687K Buy
46,322
+9,717
+27% +$144K ﹤0.01% 2323
2024
Q1
$499K Buy
36,605
+9,801
+37% +$134K ﹤0.01% 2454
2023
Q4
$294K Sell
26,804
-24,751
-48% -$271K ﹤0.01% 2575
2023
Q3
$565K Sell
51,555
-19,491
-27% -$213K ﹤0.01% 2223
2023
Q2
$941K Sell
71,046
-39,244
-36% -$520K ﹤0.01% 1973
2023
Q1
$1.45M Sell
110,290
-62,416
-36% -$823K ﹤0.01% 1726
2022
Q4
$3.37M Sell
172,706
-49,766
-22% -$972K ﹤0.01% 1374
2022
Q3
$4.24M Buy
222,472
+57,252
+35% +$1.09M ﹤0.01% 1174
2022
Q2
$3.4M Buy
165,220
+43,825
+36% +$903K ﹤0.01% 1252
2022
Q1
$3.91M Buy
121,395
+73,187
+152% +$2.35M ﹤0.01% 1181
2021
Q4
$2.25M Buy
+48,208
New +$2.25M ﹤0.01% 1318